Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis

[1]  R Müller,et al.  Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study * , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[3]  P. Christiansen.  The skeleton in primary hyperparathyroidism: A review focusing on bone remodeling, structure, mass, and fracture: Chapter 1: INTRODUCTION , 2001, APMIS. Supplementum.

[4]  R. L. Cain,et al.  Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. , 2001, Bone.

[5]  D. Burr,et al.  Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  G. Stein,et al.  Chapter 2 – Osteoblast Biology , 2001 .

[7]  R. L. Cain,et al.  Changes in Geometry and Cortical Porosity in Adult, Ovary-Intact Rabbits after 5 Months Treatment with LY333334 (hPTH 1-34) , 2000, Calcified Tissue International.

[8]  H. Sievänen,et al.  A physical model for dual-energy X-ray absorptiometry--derived bone mineral density. , 2000, Investigative radiology.

[9]  R. Weinstein,et al.  New Developments in the Pathogenesis and Treatment of Steroid‐Induced Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Toru Hirano,et al.  Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in Rabbits , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  H. Genant,et al.  Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. , 1998, The Journal of clinical investigation.

[12]  R. Lindsay,et al.  Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis , 1997, The Lancet.

[13]  F. Melsen,et al.  Reconstruction of cortical bone remodeling in untreated primary hyperparathyroidism and following surgery. , 1995, Bone.

[14]  H. Oxlund,et al.  Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats. , 1994, European journal of endocrinology.

[15]  O. Tørring,et al.  Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. , 1993, Calcified tissue international.

[16]  O. Tørring,et al.  Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  C C Glüer,et al.  Spinal bone mineral density measured with quantitative CT: effect of region of interest, vertebral level, and technique. , 1990, Radiology.

[18]  C C Glueer,et al.  Quantitative computed tomography in assessment of osteoporosis. , 1987, Seminars in nuclear medicine.

[19]  H K Genant,et al.  Quantitative computed tomography for prediction of vertebral fracture risk. , 1985, Bone.